BRAIN BIOTECH AG (BNN.DE) Stock Overview
Europe - FRA:BNN - DE0005203947 - Common Stock
BNN.DE Key Statistics, Chart & Performance
The current stock price of BNN.DE is 2.11 EUR. In the past month the price decreased by -2.76%. In the past year, price decreased by -20.97%.
BNN.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| GIN.DE | GIVAUDAN-REG | 27.51 | 34.10B | ||
| SIKA.DE | SIKA AG-REG | 23.24 | 30.55B | ||
| NZM2.DE | NOVONESIS (NOVOZYMES) B | 81.52 | 22.64B | ||
| DSFIR.AS | DSM-FIRMENICH AG | 79.88 | 19.95B | ||
| BRG.OL | BORREGAARD ASA | 21.82 | 19.38B | ||
| ELK.OL | ELKEM ASA | N/A | 18.12B | ||
| 1IFF.MI | INTL FLAVORS & FRAGRANCES | 14.02 | 13.43B | ||
| 1COV.DE | COVESTRO AG | N/A | 11.33B | ||
| SY1.DE | SYMRISE AG | 21.92 | 11.12B | ||
| AKZA.AS | AKZO NOBEL N.V. | 16.24 | 10.47B | ||
| AMC.DE | ALBEMARLE CORP | N/A | 9.71B | ||
| SYENS.BR | SYENSQO SA | 18.4 | 7.13B |
Related stock screener links
About BNN.DE
Company Profile
BRAIN Biotech AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. The company is headquartered in Zwingenberg, Hessen. The company went IPO on 2016-02-09. Biotechnology Research and Information Network AG, is a Germany -based Company. The firm is a supplier of bio-based products and solutions such as enzymes and proteins, microbial production strains, natural substances, and biotechnological solutions for industrial processes in the areas of nutrition, health, and the environment. BRAIN Biotech is also offers contract research and development in the fields of enzyme technology, microbial strain development and bioprocess development.
Company Info
BRAIN BIOTECH AG
Darmstaedter Strasse 34-36
Zwingenberg HESSEN DE
Employees: 285
Phone: 49625193310
BRAIN BIOTECH AG / BNN.DE FAQ
What is the stock price of BRAIN BIOTECH AG today?
The current stock price of BNN.DE is 2.11 EUR.
What is the ticker symbol for BRAIN BIOTECH AG stock?
The exchange symbol of BRAIN BIOTECH AG is BNN and it is listed on the Deutsche Boerse Ag exchange.
On which exchange is BNN.DE stock listed?
BNN.DE stock is listed on the Deutsche Boerse Ag exchange.
What is the price forecast or stock price prediction for BRAIN BIOTECH AG stock?
9 analysts have analysed BNN.DE and the average price target is 5.73 EUR. This implies a price increase of 171.68% is expected in the next year compared to the current price of 2.11. Check the BRAIN BIOTECH AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is BRAIN BIOTECH AG worth?
BRAIN BIOTECH AG (BNN.DE) has a market capitalization of 46.10M EUR. This makes BNN.DE a Nano Cap stock.
How many employees does BRAIN BIOTECH AG have?
BRAIN BIOTECH AG (BNN.DE) currently has 285 employees.
What are the support and resistance levels for BRAIN BIOTECH AG (BNN.DE) stock?
BRAIN BIOTECH AG (BNN.DE) has a support level at 2.04 and a resistance level at 2.11. Check the full technical report for a detailed analysis of BNN.DE support and resistance levels.
Is BRAIN BIOTECH AG (BNN.DE) expected to grow?
The Revenue of BRAIN BIOTECH AG (BNN.DE) is expected to decline by -0.63% in the next year. Check the estimates tab for more information on the BNN.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy BRAIN BIOTECH AG (BNN.DE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BNN.DE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BNN.DE, evaluating the profitability, health, valuation and growth aspects
- BRAIN BIOTECH AG (BNN.DE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BRAIN BIOTECH AG (BNN.DE) Sales and EPS estimates to see what analysts future expectations are.
- BRAIN BIOTECH AG (BNN.DE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BRAIN BIOTECH AG (BNN.DE) Insider and Institutional Ownership to learn about the owners and their transactions.
- BRAIN BIOTECH AG (BNN.DE) Stock Chart to make your own analysis
- BRAIN BIOTECH AG (BNN.DE) Latest news and press-releases to stay up to date.
Does BRAIN BIOTECH AG (BNN.DE) stock pay dividends?
BNN.DE does not pay a dividend.
When does BRAIN BIOTECH AG (BNN.DE) report earnings?
BRAIN BIOTECH AG (BNN.DE) will report earnings on 2026-01-14, after the market close.
What is the Price/Earnings (PE) ratio of BRAIN BIOTECH AG (BNN.DE)?
BRAIN BIOTECH AG (BNN.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.54).
BNN.DE Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to BNN.DE. When comparing the yearly performance of all stocks, BNN.DE is a bad performer in the overall market: 84.75% of all stocks are doing better.
BNN.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to BNN.DE. BNN.DE may be in some trouble as it scores bad on both profitability and health.
BNN.DE Financial Highlights
Over the last trailing twelve months BNN.DE reported a non-GAAP Earnings per Share(EPS) of -0.54. The EPS decreased by -33.27% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -17.27% | ||
| ROE | -227.22% | ||
| Debt/Equity | 0.74 |
BNN.DE Forecast & Estimates
9 analysts have analysed BNN.DE and the average price target is 5.73 EUR. This implies a price increase of 171.68% is expected in the next year compared to the current price of 2.11.
For the next year, analysts expect an EPS growth of 45.61% and a revenue growth -0.63% for BNN.DE